Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Search results for "United States"
Home
Colon Cancer Cases Surpass 32,000: Is Your Rectum—and Your Anus—at Risk?
Colon cancer rates continue to climb as dietary habits shift toward Westernized patterns. In 2023 alone, 32,610 new cases were reported in South...
04/01/2026, 21:04 ET
Celltrion to Double Production Capacity with 1.2 Trillion Won Investment
Celltrion has announced a massive expansion across three of its major facilities in South Korea and the United States, aiming for a total drug...
03/30/2026, 02:17 ET
Why Young Colorectal Cancer Rates are Surging in Korea: The Paradox of “High-Quality” Protein
The common refrain "you have to eat meat to have strength" reflects a cultural sentiment in Korea that is anything but...
03/27/2026, 21:42 ET
No More Pain with Every Breath: New Robotic Lung Cancer Technique Spares Rib Nerves
South Korean researchers have demonstrated the safety and effectiveness of a pioneering robotic surgical technique that...
03/24/2026, 04:19 ET
ABL Bio to Present Two Bispecific Antibody ADC Posters at AACR
ABL Bio announced on the 19th that it will participate in this year’s American Association for Cancer Research Annual...
03/24/2026, 02:47 ET
Sauna Health Benefits Are Greater Than You Think: From Brain Power to Disease Prevention
Walk into a modern fitness club and you will likely find members who skip the treadmill entirely in favor of the sauna.
03/24/2026, 02:47 ET
Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation
Celltrion announced on March 20, 2026, that it has received additional approval from Health Canada for the autoinjector...
03/23/2026, 02:59 ET
At 63, Demi Moore’s Timeless Appearance Sparks Debate: The True Cost of Hollywood Beauty?
Hollywood icon Demi Moore recently captivated fans by sharing a video update on social media, showcasing a remarkably...
03/19/2026, 04:56 ET
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation
Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...
03/18/2026, 03:08 ET
Kyungbo Pharmaceutical Passes U.S. FDA On-Site Inspection at Asan Plant
Kyungbo Pharmaceutical announced on the 18th that it passed an on-site manufacturing inspection by the U. S.
03/18/2026, 03:08 ET
Previous
7
8
9
10
11
Next
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية